Recent advances in PKU treatment include enzyme replacement therapy, gene therapy, and the use of phenylalanine ammonia lyase (PAL) to metabolize excess phenylalanine. Research is ongoing to develop more effective treatments that can reduce the toxicological impact of phenylalanine, potentially improving the quality of life for individuals with PKU.
